© 2002 by European Society of Cardiology
Copyright © 2002, European Society of Cardiology
Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice
aInstitute of Pharmacology and Toxicology, University of Münster, Domagkstrasse 12, D-48129 Münster, Germany
bInstitute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany
mkuhn{at}uni-muenster.de
* Corresponding author. Tel.: +49-251-835-2597; fax: +49-251-835-5501
Objective: The natriuretic peptides (NPs), atrial (ANP), B-type (BNP), and C-type (CNP) natriuretic peptides as well as their respective receptor-guanylyl cyclases (GC-A for ANP and BNP, and GC-B for CNP) are expressed in the heart. However, the local role of NPs in the regulation of cardiac contractility and the mutual interactions of NPs remain controversial. In the present study we evaluated the effects of ANP and CNP on cardiac function of wild-type (GC-A +/+) and GC-A-deficient (GC-A –/–) mice. Methods: The effects of NPs and their molecular mechanisms were assessed in the isolated perfused mouse working heart preparation. Results: In GC-A +/+ hearts, CNP exerted a biphasic action: an immediate increase in inotropy and lusitropy, followed by a slowly developing negative inotropic effect. These effects were mimicked by the cGMP-analogue, 8-pCPT-cGMP. In contrast, ANP did not affect cardiac function. In GC-A –/– hearts, the immediate contractile responses to CNP and 8-pCPT-cGMP were significantly enhanced. CNP increased cardiac cGMP levels and stimulated phospholamban (PLB) phosphorylation; the effect on PLB, but not cGMP, was enhanced in GC-A –/– hearts. In addition, cardiac expression of cGMP-dependent protein kinase (cGK I) was significantly increased in GC-A –/– mice. Conclusion: CNP exerts a biphasic, initially positive inotropic and lusitropic, then negative inotropic effect in isolated working mouse hearts. A putative mechanism contributing to the immediate contractile responses is cGMP/cGK I-dependent phosphorylation of PLB and subsequent activation of the sarcoplasmic reticulum Ca2+-pump. ANP has no direct effects on cardiac contractility but chronic absence of its receptor, GC-A, results in increased responsiveness to CNP.
KEYWORDS Natriuretic peptide; Hypertension; Hypertrophy; Contractile function; Gene expression
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Zaccolo and M. A. Movsesian cAMP and cGMP Signaling Cross-Talk: Role of Phosphodiesterases and Implications for Cardiac Pathophysiology Circ. Res., June 8, 2007; 100(11): 1569 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Langenickel, J. Buttgereit, I. Pagel-Langenickel, M. Lindner, J. Monti, K. Beuerlein, N. Al-Saadi, R. Plehm, E. Popova, J. Tank, et al. Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B PNAS, March 21, 2006; 103(12): 4735 - 4740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mattiazzi, C. Mundina-Weilenmann, C. Guoxiang, L. Vittone, and E. Kranias Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions Cardiovasc Res, December 1, 2005; 68(3): 366 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hambleton, J. Krall, E. Tikishvili, M. Honeggar, F. Ahmad, V. C. Manganiello, and M. A. Movsesian Isoforms of Cyclic Nucleotide Phosphodiesterase PDE3 and Their Contribution to cAMP Hydrolytic Activity in Subcellular Fractions of Human Myocardium J. Biol. Chem., November 25, 2005; 280(47): 39168 - 39174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Su, P. M. Scholz, and H. R. Weiss Differential Effects of cGMP Produced by Soluble and Particulate Guanylyl Cyclase on Mouse Ventricular Myocytes Experimental Biology and Medicine, April 1, 2005; 230(4): 242 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Layland, R. J. Solaro, and A. M. Shah Regulation of cardiac contractile function by troponin I phosphorylation Cardiovasc Res, April 1, 2005; 66(1): 12 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Su, Q. Zhang, J. Moalem, J. Tse, P. M. Scholz, and H. R. Weiss Functional effects of C-type natriuretic peptide and nitric oxide are attenuated in hypertrophic myocytes from pressure-overloaded mouse hearts Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1367 - H1373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Chitapanarux, S. L. Chen, H. Lee, A. C. Melton, and H. F. Yee Jr. C-type natriuretic peptide induces human colonic myofibroblast relaxation Am J Physiol Gastrointest Liver Physiol, January 1, 2004; 286(1): G31 - G36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Su, S. Zhang, J. Tse, P. M. Scholz, and H. R. Weiss Alterations in nitric oxide-cGMP pathway in ventricular myocytes from obese leptin-deficient mice Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2111 - H2117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sabrane, S. Gambaryan, R. P. Brandes, R. Holtwick, M. Voss, and M. Kuhn Increased Sensitivity to Endothelial Nitric Oxide (NO) Contributes to Arterial Normotension in Mice with Vascular Smooth Muscle-selective Deletion of the Atrial Natriuretic Peptide (ANP) Receptor J. Biol. Chem., May 9, 2003; 278(20): 17963 - 17968. [Abstract] [Full Text] [PDF]
|
|